Origin Therapeutics Holdings Inc.
Origin Therapeutics Holdings Inc.
Listing Exchange:
CSEStatus:
Halted Pending Fundamental ChangeIndustry:
Diversified IndustriesSymbol:
ORIGCSE Index:
Currency:
Origin is an investment issuer that has historically focused on making equity investments in psychedelics-industry-related companies to provide investors with diverse exposure to the sector. On December 8, 2022, the Company announced that its board of directors had initiated a review process to consider, review and evaluate strategic alternatives for the Company.
Origin Therapeutics Holdings Inc. (ORIG)
SEDAR Information
Company Info
Address
1570-505 Burrard Street
Vancouver, BC V7X 1M5
CanadaPhone
(604) 416-4099Email
Klee@k2capital.caWebsite
https://www.originpsychedelics.comListing date
Monday, June 6, 2022Transfer Agent
Olympia Trust CompanyCapitalization
Issued & Outstanding:
56,563,000Reserved for Issuance:
3,098,700Company Officers
Michael Galego, Interim CEO
Kelvin Lee, Chief Financial Officer and Corporate Secretary
Bulletins
02/06/2022
2022-0604 - New Listing - Origin Therapeutics Holdings Inc. (ORIG)
le juin 2/June 2022
The common shares of Origin Therapeutics Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.
Advertisement
Publicité
